Medincell
Jacou, FR· latest recorded location
MEDINCELL is named on 15 US grants and 38 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 15
- Published applications
- 38
- Inventors
- 48
- Granted in 2026 so far
- 3
- Most recent grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 3 |
| 2020 | 0 | 5 |
| 2021 | 0 | 4 |
| 2022 | 0 | 4 |
| 2023 | 3 | 2 |
| 2024 | 2 | 10 |
| 2025 | 5 | 2 |
| 2026 | 3 | 3 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 53 documents
- A61KMedicines and medical preparations51
- A61PTherapeutic uses of medicines33
- C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds18
- C08LCompositions of macromolecular compounds18
- A01NPreservation of bodies of humans or animals or plants or parts thereof10
- A61MDevices for delivering substances into the body3
- G05DSystems for controlling or regulating non-electric variables2
- Y10TTechnical subjects covered by former us classification2
- C07KPeptides1
Recent patents
- Long acting injectable formulation comprising risperidone and biodegradable polymers29 Sep 2026US 12,746,197 B2
- Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue24 Feb 2026US 12,558,309 B2
- Flow control device24 Feb 2026US 12,560,950 B2
- Pharmaceutical composition2 Dec 2025US 12,485,139 B2
- Pharmaceutical composition30 Sep 2025US 12,427,165 B2
- Olanzapine compositions and methods of use30 Jul 2026US 2026/0216206 A1
- Pharmaceutical composition30 Apr 2026US 2026/0115226 A1
- Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue12 Mar 2026US 2026/0069532 A1
- Drug delivery formulations28 Aug 2025US 2025/0268817 A1
- Pharmaceutical composition9 Jan 2025US 2025/0009647 A1
Most cited
By later US patents